Please assess the completion status of the following clinical trial:

Trial Title: Treatment Study of Carnosine Versus Placebo in Gulf War Illness (GWI)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Evidence of military enlistment between August 1, 1990 and July 31, 1991, and deployment for 30 consecutive days to:~  * Persian Gulf waters and adjacent land areas,~ * Other global locations, or,~ * U.S. only. 1990-1991 enlistment status:~ * Active duty~ * National Guard~ * Reserves~Exclusion Criteria:~* HIV/AIDS~* Pregnant Women~* Active Duty Military Personnel~* Children~* Incarceration

- Gender: ALL
- Minimum Age: 34 Years
- Maximum Age: 82 Years
- Healthy Volunteers: f

Study Arms:
- Carnosine treatment group (Type: ACTIVE_COMPARATOR): Carnosine treatment group
- Placebo control group (Type: PLACEBO_COMPARATOR): Placebo control group

Based on this trial design, predict the completion outcome and termination type (if applicable).